Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed by Yescarta – in August and October, respectively. Approved in August 2017, before Novartis named the drug Kymriah (Tisagenlecleucel) – it…
TrialX is excited to participate and present in AMIA 2017, the 41st anniversary of the annual symposia conducted by the American Medical Informatics Association (AMIA). Every year, leading informaticians such as – translational scientists, clinicians,…
iConnect 2.0 is a specifically designed online platform that facilitates patient-recruitment for academic medical centers, sponsors, and patient advocacy groups. iConnect 2.0 helps overcome challenges of patient recruitment in clinical trials by: Creating a…
TrialX team had an exhilarating day on day1 of #DIA2017. Our CEO Sharib Khan, CTO Chintan Patel, creative director Aziz Rawat, and VP Clinical Trial Solutions Robert Ryan spent the day presenting our #patientengagement #patientrecruitment and…
Patient centricity has not always been the focus of the healthcare industry. About a decade back the role of the patient in healthcare product development was not considered to be that important, with healthcare companies…
iConnect V.2 is about to be launched and we are very excited. Our team is working hard to meet timelines and bring to production enhanced features, UI changes and more. We mentioned how investigators can make…
We are excited to participate and exhibit at the 53rd DIA 2017 Global Annual Meeting. Meet us at booth#2513. Our featured product this year is a no code DIY research study app making platform – called Appbakery. We…
